A detailed history of Advisor Partners LLC transactions in Incyte Corp stock. As of the latest transaction made, Advisor Partners LLC holds 2,946 shares of INCY stock, worth $222,275. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,946
Holding current value
$222,275
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$66.18 - $83.18 $194,966 - $245,048
2,946 New
2,946 $224,000
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $164,670 - $201,479
-2,398 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$79.87 - $87.53 $19,648 - $21,532
-246 Reduced 9.3%
2,398 $202,000
Q4 2020

Feb 17, 2021

SELL
$80.74 - $97.7 $1,130 - $1,367
-14 Reduced 0.53%
2,644 $230,000
Q3 2020

Nov 19, 2020

SELL
$85.07 - $109.69 $10,718 - $13,820
-126 Reduced 4.53%
2,658 $239,000
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $206,517 - $303,261
2,784 New
2,784 $289,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.